As per DelveInsight, the global Nerve Repair and Regeneration market was valued at USD 6,497.47 million in 2021 and is anticipated to grow at a CAGR of 9.31% during the forecast period from 2022 to 2027. Some of the key factors, such as the increasing incidence of nerve injuries, the rising prevalence of lifestyle disorders (such as diabetes, hypertension, and others), technological advancements in the nerve repair product portfolio, and product approvals & launches, among others, are anticipated to drive the Nerve Repair and Regeneration market growth. The leading companies in the Global Nerve Repair and Regeneration Market include Medtronic, Boston Scientific Corporation, AxoGen Inc., Baxter International, Checkpoint Surgical, Inc., Integra Lifesciences, Polyganics B.V., Orthomed S.A.S, Salumedica, LLC, Alafair Biosciences, Inc., Neurometrix, Inc., TOYOBO CO., LTD, LivaNova PLC, Synapse Biomedical, Inc., Abbott, Keri Medical, Nevro Corp., Collagen matrix, Inc., Aleva Neurotherapeutics SA, Orthocell, Ltd., among others.
DelveInsight’s “Nerve Repair and Regeneration Market Insight, Competitive Landscape and Market Forecast – 2027” research report provides the current and forecasted Nerve Repair and Regeneration market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.
Nerve Repair and Regeneration Market: Overview
Nerve repair is a complex biological process that starts immediately after a nerve injury occurs. Nerve repair consists of an approximation of the ends of an injured nerve via the direct form of nerve repair, nerve grafts, or nerve tubes. Nerve regeneration is the regrowth of the nervous tissue via the generation of new neurons, axons, synapses, and glial cells. The products mainly for Nerve Repair and Regeneration include nerve conduits, nerve protectors, nerve caps in biomaterial, and neuromodulation devices.
DelveInsight’s “Nerve Repair and Regeneration Market” report provides an in-depth assessment of the market, segmented by type product type (biomaterials [nerve connectors/conduits, nerve protectors, nerve wraps, and nerve graft {autografts, allografts, and xenografts}] and neuromodulation devices [external neuromodulation devices {transcutaneous electrical nerve stimulation devices and transcranial magnetic stimulation devices} and internal neuromodulation devices {spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, and others devices}]), end-user (hospitals & clinics, ambulatory surgical centers, and others), and geography (North America, Europe, Asia-pacific, and rest of the world).
As per the assessment, in the Nerve Repair and Regeneration product segment, the nerve protector’s sub-segment in the biomaterials category is estimated to grow significantly owing to the various advantages associated with nerve protectors. Moreover, the increase in product launches, approvals, and other regulatory steps, in the local market is also anticipated to increase the overall market growth of the nerve protectors.
Nerve Repair and Regeneration Market Analysis
The Nerve Repair and Regeneration Market is anticipated to grow in the coming years owing to the rising prevalence of lifestyle-associated disorders such as diabetes and hypertension. According to the IDF, nearly 537 million adults were living with diabetes in the year 2021, which is further expected to rise to 700 million by 2045. Diabetes is considered one of the major risk factors that may lead to the development of peripheral nerve neuropathy and can lead to mild to severe forms of damage to the sensory, motor, and autonomic nerves. The devices such as neuromodulation devices are used for management or treatment of nerve repair and regeneration in a diabetic patient, thereby increasing its demand in the market. Thus, diabetes may act as potential factor for the market growth of nerve repair and regeneration products. Additionally, rising cases of traumatic injuries due to road accidents, occupational accidents, and falls, among others, could lead to peripheral nerve injuries, thereby raising the demand for Nerve Repair and Regeneration products.
However, the high cost associated with Nerve Repair and Regeneration products and the availability of alternative treatment methods are likely to hinder the Nerve Repair and Regeneration market in the forthcoming years.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight into Nerve Repair and Regeneration Types and Emerging Products
Nerve Repair and Regeneration- Global Market Assessment and Forecast
As per DelveInsight’s analysis, among all the regions, North America is expected to dominate the Nerve Repair and Regeneration market in the coming years. Some of the key factors, such as the rise in the number of neurological conditions in the region, are anticipated to play a key role in the rising demand for Nerve Repair and Regeneration products. In addition, the growth in the number of chronic pain associated with nerve and neurology-associated disorders is also expected to drive the growth of the Nerve Repair and Regeneration market.
Furthermore, the strong presence of leading Nerve Repair and Regeneration companies, strong R&D, and regulatory guidelines, among others, are anticipated to stimulate the Nerve Repair and Regeneration Market growth in the region in the coming years. The North Americas has a strong presence of well-established MedTech players such as Boston Scientific Incorporation, Medtronic plc., Stryker Corporation, and Nevro Corporation, which contribute to the Nerve Repair and Regeneration market growth.
Furthermore, Europe holds the second-largest market for Nerve Repair and Regeneration products. Some of the key factors, such as the approvals and launches of new products, the growth in nerve injuries, rising acquisitions and mergers, and increasing lifestyle-related disorders, among others, are anticipated to drive the Nerve Repair and Regeneration market growth in the European region.
Interested in knowing how the market will grow by 2027? Click to get a snapshot of Nerve Repair and Regeneration Market Trends and Developments
Nerve Repair and Regeneration Market – Key Developments and Breakthroughs
Over the years, the Nerve Repair and Regeneration market has evolved significantly owing to the active participation of the global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered. Some of the major advancements in the Nerve Repair and Regeneration Market in recent years include –
- In July 2022, Pulsetto, a healthtech startup, launched a neuromodulation device that stimulates the vagus nerve. Stimulating this nerve with electric impulses activates the parasympathetic nervous system, allowing the body to rest and relax. This device can be used for nerve regeneration.
- In March 2022, Integra LifeSciences, introduced NeuraGen 3D Nerve Guide Matrix, a resorbable implant to repair peripheral nerve discontinuities. This product is developed to make an optimized environment, enabling a complete functional recovery following mid-gap nerve repair, compared to hollow nerve conduits alone.
- In January 2022, Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, announced it had enrolled the first patient in its multi-center clinical study of the company’s breakthrough nerve regeneration technology, Checkpoint BEST (Brief Electrical Stimulation Therapy) system.
Learn more about the ongoing development in the market @ Nerve Repair and Regeneration Market – Clinical and Commercial Development Activities
Key Companies in the Nerve Repair and Regeneration Market
Globally, some of the leading MedTech giants working in the Nerve Repair and Regeneration Market include Medtronic, Boston Scientific Corporation, AxoGen Inc., Baxter International, Checkpoint Surgical, Inc., Integra Lifesciences Corporation, Polyganics B.V., Orthomed S.A.S, Salumedica, LLC, Alafair Biosciences, Inc., Neurometrix, Inc., TOYOBO CO., LTD, LivaNova PLC, Synapse Biomedical, Inc., Abbott, Keri Medical, Nevro Corp., Collagen matrix, Inc., Aleva Neurotherapeutics SA, Orthocell, Ltd., among others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.
Learn how new players’ entries will transform the market dynamics in the coming years @
Nerve Repair and Regeneration Competitive Landscape
Scope of the Nerve Repair and Regeneration Market Report:
- Study Period – 2019-2027
- Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
- Nerve Repair and Regeneration Market Assessment –
-
-
- By Product Type – Biomaterials [Nerve Connectors/Conduits, Nerve Protectors, Nerve Wraps, and Nerve Graft {Autografts, Allografts, and Xenografts}] and Neuromodulation Devices [External Neuromodulation Devices {Transcutaneous Electrical Nerve Stimulation Devices and Transcranial Magnetic Stimulation Devices} and Internal Neuromodulation Devices {Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Others Devices}].
- End-User – Hospitals & Clinics, Ambulatory Surgical Centers, and Others
-
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
Table of Content
| 1 | Report Introduction |
| 2 | Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Nerve Repair and Regeneration Market Key Factors Analysis |
| 5 | Nerve Repair and Regeneration Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on the Nerve Repair and Regeneration Market |
| 7 | Nerve Repair and Regeneration Market Layout |
| 8 | Nerve Repair and Regeneration Global Company Share Analysis – Key 3–5 Companies |
| 9 | Nerve Repair and Regeneration Product Profiles and Key Companies |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Reach out to us to get a more detailed overview of the market @
Nerve Repair and Regeneration Market Insights and Competitive Landscape
Other Trending Report by DelveInsight
Neuromodulation Devices Market
Global Neuromodulation Devices Market was valued at USD 5.71 billion in 2021, growing at a CAGR of 8.95% during the forecast period from 2022 to 2027, to reach USD 9.56 billion. Some of the leading players operating in the market include Medtronic, Boston Scientific Corporation, Abbott, LivaNova, NeuroSigma, NEVRO CORP., Synapse Biomedical Inc., and others.
Spinal Cord Stimulators (SCS) Market
Global Spinal Cord Stimulators (SCS) Market was valued at USD 2.25 billion in 2021, growing at a CAGR of 8.70% during the forecast period from 2022 to 2027 to reach USD 3.72 billion by 2027. The leading companies in the SCS Market include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., and others.
Deep Brain Stimulation Devices Market
Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2021, growing at a CAGR of 10.40% during the forecast period from 2022 to 2027 to reach USD 2.37 billion by 2027. Some of the key market players operating in the Global DBS systems market are Abbott, Medtronic, Boston Scientific Corporation, Newronika S.p.A., Beijing PINS Medical Co., Ltd., and others.
Sacral Nerve Stimulator Devices Market
“Sacral Nerve Stimulator Devices Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of the historical and forecasted Sacral Nerve Stimulator Devices market trends globally, which comprises North America, Europe, APAC, and RoW.
Vagus Nerve Stimulator (VNS) Market
Global vagus nerve stimulators market was valued at USD 426.22 million in 2021, growing at a CAGR of 9.06% during the forecast period from 2022 to 2027 to reach USD 717.17 million by 2027. Some of the key market players operating in the vagus nerve stimulators market include LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others.
Global Diabetic Wounds Market was valued at USD 2.22 Billion in 2021, growing at a CAGR of 7.48% during the forecast period from 2022 to 2027 to reach USD 3.44 Billion by 2027. The leading companies in the Diabetic Wounds market include B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Cardinal Health, BSN medical Inc, and others.
Diabetic Peripheral Neuropathy Market
“Diabetic Peripheral Neuropathy Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of the Diabetic Peripheral Neuropathy, historical and forecasted epidemiology as well as the Diabetic Peripheral Neuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Peripheral Nerve Repair Devices Market
Global Peripheral Nerve Repair Devices Market is projected to grow at a 10.76% CAGR during the forecast period from 2022 to 2027. Some of the key market players operating in the peripheral nerve repair devices market includes Integra LifeSciences, Axogen Inc, Medovent GmbH, Stryker, Toyobo Co. Ltd, Cook Biotech Products, and others.
Diabetic Peripheral Neuropathy (DPN) Epidemiology Forecast
“Diabetic Peripheral Neuropathy (DPN) Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Diabetic Peripheral Neuropathy (DPN) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
“Diabetes Pipeline Insights, 2023” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products by type, stage, route of administration, and molecule type.
“Hypertension Pipeline Insight, 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products by type, stage, route of administration, and molecule type.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Partner Identification Solutions and Healthcare Portfolio Management Services.
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187